NCT02005263

Brief Summary

Disease of the fallopian tubes is one of the most common reasons for infertility. The most common test, a hysterosalpingogram, tends to be painful,inconvenient, and frequently misses concurrent uterine disease. We propose using a less painful technique (through modified office hysteroscopy) for tubal assessment that can be performed in the office rather than hospital radiology and that uses gold standard technology for identifying coexisting uterine conditions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
621

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2013

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

December 3, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 9, 2013

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 16, 2017

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 6, 2017

Completed
Last Updated

November 8, 2017

Status Verified

November 1, 2017

Enrollment Period

3.9 years

First QC Date

December 3, 2013

Last Update Submit

November 6, 2017

Conditions

Keywords

Hysteroscopy

Outcome Measures

Primary Outcomes (1)

  • Hysteroscopic assessment of tubal patency

    Patients undergoing the procedure will be informed based on the findings as to whether or not it is believed that their Fallopian tubes are patent

    2 years

Study Arms (1)

Salpingography

EXPERIMENTAL

Infusion of air bubbles through Fallopian tubes with hysteroscopic visualization; typically 1-2 mL is infused. This is less than that typically used in the established technique of sonosalpingography.

Procedure: Salpingography

Interventions

Infusion of typically 1-2 mL of air bubbles in to the uterine cavity to assess whether they disappear through the ostia in to the Fallopian tubes.

Also known as: Parryscope technique
Salpingography

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • years old
  • Able to give consent
  • Must have a uterus
  • Must have documented negative testing for gonorrhea and chlamydia within the past year or previously negative when tested with a current partner in a monogamous relationship
  • Negative test prior to procedure

You may not qualify if:

  • Pregnancy
  • Active lower and upper genital tract infection
  • Patients with allergies to hysterosalpingogram contrast will not be exposed to a contrast material to which they are allergic
  • Premenarchal or postmenopausal
  • Unable to read English at a 6th grade level or above
  • History of endometrial Ablation
  • Asherman's syndrome \> Stage 1

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Mississippi Medical Center

Jackson, Mississippi, 39216, United States

Location

Related Publications (1)

  • Parry JP, Riche D, Rushing J, Linton B, Butler V, Lindheim SR. Performing the Parryscope technique gently for office tubal patency assessment. Fertil Steril. 2017 Oct;108(4):718. doi: 10.1016/j.fertnstert.2017.07.1159. Epub 2017 Aug 31.

MeSH Terms

Conditions

InfertilityMenorrhagia

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital DiseasesUterine HemorrhageUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsMenstruation Disturbances

Study Officials

  • John P. Parry, MD

    University of Mississippi Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 3, 2013

First Posted

December 9, 2013

Study Start

December 1, 2013

Primary Completion

October 16, 2017

Study Completion

November 6, 2017

Last Updated

November 8, 2017

Record last verified: 2017-11

Locations